Full Press Release Details
Viking Therapeutics to Report Financial Results for Third Quarter 2023 on October 25, 2023.
VKTX
Viking Therapeutics to Report Financial Results for Third Quarter 2023 on October 25, 2023
Key Takeaway: Viking Therapeutics to Report Financial Results for Third Quarter 2023 on October 25, 2023
Price reaction · baseline $10.72 (2023-10-17 close) · hit after-hours · 1 other VKTX headline(s) in the window, move may be shared
day 0 close · peak
-3.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+53%
120-day peak, hindsight
Typical move
13.6%
average across 5 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
VK2735
Phase 3 · Weight Loss